Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-03-07 00:04 | 2009-03-04 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $6.73 | 300,000 | $2,017,950 | 28,758,029 |
| 2009-03-07 02:29 | 2009-03-04 | HAE | HAEMONETICS CORP | White Jonathan | Officer | BUY | $53.49 | 1,500 | $80,239 | 1,500 |
| 2009-03-07 03:12 | 2009-03-04 | OCLS | Sonoma Pharmaceuticals, Inc. | Burlingame Robert | Director | BUY | $1.17 | 218,234 | $255,334 | 289,233 |
| 2009-03-07 02:01 | 2008-12-01 | ATEC | Alphatec Holdings, Inc. | Hochschuler Stephen | Director | BUY | $1.65 | 20,000 | $33,000 | 102,183 |
| 2009-03-07 01:23 | 2009-03-06 | MELA | STRATA Skin Sciences, Inc. | Cleary Martin D | Director | BUY | $4.00 | 4,105 | $16,420 | 30,443 |
| 2009-03-06 03:21 | 2009-03-03 | OCLS | Sonoma Pharmaceuticals, Inc. | Alimi Hojabr | Director, Officer | OPT+S | $1.17 | 31,800 | $37,139 | 1,024,450 |
| 2009-03-06 00:41 | 2009-03-05 | MELA | STRATA Skin Sciences, Inc. | Cleary Martin D | Director | BUY | $4.00 | 895 | $3,580 | 26,338 |
| 2009-03-06 00:07 | 2009-03-05 | MELA | STRATA Skin Sciences, Inc. | Chryssis George C | Director | BUY | $4.02 | 1,000 | $4,020 | 41,000 |
| 2009-03-05 18:43 | 2009-03-05 | MELA | STRATA Skin Sciences, Inc. | Gulfo Joseph V | Director, Officer | BUY | $4.09 | 5,000 | $20,426 | 106,853 |
| 2009-03-05 00:26 | 2009-03-02 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $6.77 | 300,000 | $2,029,800 | 29,058,029 |
| 2009-03-05 00:25 | 2009-03-02 | BSX | BOSTON SCIENTIFIC CORP | NICHOLAS PETER M | Director | SELL | $6.73 | 460,256 | $3,096,188 | 16,094,010 |
| 2009-03-04 01:38 | 2009-03-02 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | Officer | OPT+S | $51.93 | 9,750 | $506,319 | 29,917 |
| 2009-03-04 02:23 | 2009-02-27 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $37.10 | 1,700 | $63,071 | 198,700 |
| 2009-03-03 16:37 | 2009-02-27 | WST | WEST PHARMACEUTICAL SERVICES INC | ANDERSON MICHAEL A | Officer | OPT+S | $30.00 | 10,000 | $299,987 | 29,836 |
| 2009-03-03 04:55 | 2009-02-26 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $39.32 | 9,000 | $353,912 | 199,400 |
| 2009-02-27 18:57 | 2008-12-04 | MELA | STRATA Skin Sciences, Inc. | Lufkin Dan W | Director | BUY | $3.75 | 1,000 | $3,750 | 6,847 |
| 2009-02-27 18:52 | 2007-02-20 | MELA | STRATA Skin Sciences, Inc. | Lufkin Dan W | Director | BUY | $5.14 | 5,000 | $25,696 | 424,765 |
| 2009-02-27 00:06 | 2009-02-24 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.23 | 200,000 | $1,646,000 | 29,358,029 |
| 2009-02-26 20:48 | 2009-02-25 | WST | WEST PHARMACEUTICAL SERVICES INC | WORDEN GEOFFREY F | Director | SELL | $31.50 | 932 | $29,358 | 11,786 |
| 2009-02-26 00:05 | 2009-02-23 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.26 | 100,000 | $825,500 | 29,558,029 |
| 2009-02-25 17:06 | 2009-02-24 | WST | WEST PHARMACEUTICAL SERVICES INC | WORDEN GEOFFREY F | Director | OPT+S | $31.41 | 6,000 | $188,483 | 12,717 |
| 2009-02-25 01:23 | 2009-02-24 | ICUI | ICU MEDICAL INC/DE | COSTELLO RICHARD A | Officer | SELL | $32.89 | 494 | $16,248 | 0 |
| 2009-02-24 19:19 | 2009-02-23 | WST | WEST PHARMACEUTICAL SERVICES INC | WELTERS ANTHONY | Director | OPT+S | $30.90 | 5,250 | $162,225 | 7,189 |
| 2009-02-24 00:02 | 2009-02-19 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.53 | 400,000 | $3,410,920 | 29,658,029 |
| 2009-02-24 04:13 | 2008-12-15 | CERS | CERUS CORP | CASSIN BJ | Director | BUY | $0.71 | 100,000 | $71,160 | 487,921 |
| 2009-02-21 01:03 | 2009-02-18 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.45 | 150,000 | $1,267,800 | 30,058,029 |
| 2009-02-21 03:42 | 2009-02-18 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $41.66 | 15,000 | $624,858 | 6,435 |
| 2009-02-20 04:36 | 2009-02-19 | ICUI | ICU MEDICAL INC/DE | BRUMMETT BURCAR ALISON | Officer | SELL | $35.61 | 618 | $22,008 | 0 |
| 2009-02-19 01:44 | 2009-02-17 | HAE | HAEMONETICS CORP | NUTTER BRAD | Director, Officer | OPT+S | $59.85 | 100,000 | $5,984,950 | 9,020 |
| 2009-02-18 00:07 | 2009-02-13 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.91 | 175,000 | $1,559,775 | 30,208,029 |
| 2009-02-17 20:04 | 2009-02-13 | ICUI | ICU MEDICAL INC/DE | Lamb Scott E | Officer | BUY | $26.29 | 126 | $3,313 | 957 |
| 2009-02-18 01:50 | 2009-02-13 | ANGO | Angiodynamics Inc. | HOBBS EAMONN P | Director, Officer | SELL | $12.99 | 15,000 | $194,775 | 100,401 |
| 2009-02-17 20:04 | 2009-02-13 | ICUI | ICU MEDICAL INC/DE | BRUMMETT BURCAR ALISON | Officer | BUY | $26.29 | 618 | $16,248 | 618 |
| 2009-02-17 20:05 | 2009-02-13 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | BUY | $26.29 | 247 | $6,494 | 1,018 |
| 2009-02-17 20:04 | 2009-02-13 | ICUI | ICU MEDICAL INC/DE | COSTELLO RICHARD A | Officer | BUY | $26.29 | 494 | $12,988 | 494 |
| 2009-02-14 00:10 | 2009-02-11 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.74 | 300,000 | $2,622,450 | 30,383,029 |
| 2009-02-14 01:23 | 2009-02-11 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $41.16 | 10,000 | $411,600 | 1,360 |
| 2009-02-14 01:21 | 2009-02-11 | RMD | RESMED INC | Gallahue Kieran | Director, Officer | OPT+S | $41.76 | 15,000 | $626,400 | 3,224 |
| 2009-02-14 01:31 | 2009-02-12 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $42.26 | 17,607 | $743,993 | 2,863 |
| 2009-02-14 01:26 | 2009-02-12 | RMD | RESMED INC | QUINN MICHAEL A | Director | SELL | $42.50 | 10,000 | $425,000 | 130,270 |
| 2009-02-14 01:31 | 2009-02-12 | BAX | BAXTER INTERNATIONAL INC | STALLKAMP THOMAS T | Director | OPT+S | $58.52 | 10,590 | $619,727 | 19,981 |
| 2009-02-13 00:04 | 2009-02-10 | ARAY | Accuray Incorporated | President International Investment Holdings Ltd. | 10% owner | SELL | $5.47 | 500,000 | $2,732,500 | 9,168,921 |
| 2009-02-12 02:51 | 2009-02-09 | RMD | RESMED INC | QUINN MICHAEL A | Director | SELL | $41.53 | 10,000 | $415,260 | 140,270 |
| 2009-02-07 00:05 | 2009-02-05 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | SELL | $73.94 | 3,603 | $266,406 | 18,090 |
| 2009-02-07 00:03 | 2009-02-04 | BDX | BECTON DICKINSON & CO | CONSIDINE JOHN R | Officer | OPT+S | $73.92 | 90,000 | $6,652,800 | 89,650 |
| 2009-02-06 00:50 | 2009-02-04 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | OPT+S | $62.85 | 13,000 | $817,050 | 641 |
| 2009-02-05 01:07 | 2008-10-31 | BSX | BOSTON SCIENTIFIC CORP | Kucheman William | Officer | BUY | $6.54 | 4,600 | $30,070 | 21,417 |
| 2009-02-04 02:56 | 2009-02-02 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $63.00 | 3,000 | $189,000 | 4,508 |
| 2009-02-04 00:07 | 2009-02-02 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | SELL | $40.00 | 5,000 | $200,000 | 812,672 |
| 2009-02-03 17:13 | 2008-12-01 | PODD | INSULET CORP | Campbell Robert | Officer | BUY | $4.40 | 1,000 | $4,400 | 60,094 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.